Girentuximab Withdrawn Phase 3 Trials for Renal Cancer / Renal Cell Carcinoma (RCC) Diagnostic
Indications | Status | Purpose | Phase |
---|---|---|---|
Withdrawn | Diagnostic | 3 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT01762592 | REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT |